Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences total assets
Total assets on the balance sheet at the end of each period.
Interpace Biosciences's total assets was $34.55M at Jun 30, 2026. For fiscal 2025 it was $33.84M, up 128.8% from the year before. Over ten years it grew -6.3% a year on average. The highest annual figure on record is $124.39M in fiscal 2010.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.84M | +128.8% |
| FY2024 | Dec 31, 2024 | $14.79M | +12.8% |
| FY2023 | Dec 31, 2023 | $13.12M | -17.9% |
| FY2022 | Dec 31, 2022 | $15.98M | -58.4% |
| FY2021 | Dec 31, 2021 | $38.43M | -15.9% |
| FY2020 | Dec 31, 2020 | $45.68M | -11.4% |
| FY2019 | Dec 31, 2019 | $51.54M | +65.6% |
| FY2018 | Dec 31, 2018 | $31.13M | -15.0% |
| FY2017 | Dec 31, 2017 | $36.62M | +45.7% |
| FY2016 | Dec 31, 2016 | $25.14M | -61.2% |
| FY2015 | Dec 31, 2015 | $64.74M | -43.8% |
| FY2014 | Dec 31, 2014 | $115.21M | +66.8% |
| FY2013 | Dec 31, 2013 | $69.06M | -12.0% |
| FY2012 | Dec 31, 2012 | $78.45M | -30.8% |
| FY2011 | Dec 31, 2011 | $113.38M | -8.9% |
| FY2010 | Dec 31, 2010 | $124.39M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.55M | +180.1% |
| Q1 FY2026 | Mar 31, 2026 | $33.41M | +130.5% |
| Q4 FY2025 | Dec 31, 2025 | $33.84M | +128.8% |
| Q3 FY2025 | Sep 30, 2025 | $12.04M | -14.3% |
| Q2 FY2025 | Jun 30, 2025 | $12.34M | -4.9% |
| Q1 FY2025 | Mar 31, 2025 | $14.49M | +19.4% |
| Q4 FY2024 | Dec 31, 2024 | $14.79M | +12.8% |
| Q3 FY2024 | Sep 30, 2024 | $14.04M | -1.5% |
| Q2 FY2024 | Jun 30, 2024 | $12.97M | -19.2% |
| Q1 FY2024 | Mar 31, 2024 | $12.14M | -24.0% |
| Q4 FY2023 | Dec 31, 2023 | $13.12M | -17.9% |
| Q3 FY2023 | Sep 30, 2023 | $14.25M | -6.8% |
| Q2 FY2023 | Jun 30, 2023 | $16.06M | -54.7% |
| Q1 FY2023 | Mar 31, 2023 | $15.98M | -58.3% |
| Q4 FY2022 | Dec 31, 2022 | $15.98M | -58.4% |
| Q3 FY2022 | Sep 30, 2022 | $15.29M | -62.1% |
| Q2 FY2022 | Jun 30, 2022 | $35.49M | -17.8% |
| Q1 FY2022 | Mar 31, 2022 | $38.36M | -12.5% |
| Q4 FY2021 | Dec 31, 2021 | $38.43M | -15.9% |
| Q3 FY2021 | Sep 30, 2021 | $40.31M | -20.5% |
| Q2 FY2021 | Jun 30, 2021 | $43.19M | -28.8% |
| Q1 FY2021 | Mar 31, 2021 | $43.86M | -27.8% |
| Q4 FY2020 | Dec 31, 2020 | $45.68M | -11.4% |
| Q3 FY2020 | Sep 30, 2020 | $50.70M | -32.1% |
| Q2 FY2020 | Jun 30, 2020 | $60.61M | +20.4% |
| Q1 FY2020 | Mar 31, 2020 | $60.78M | +11.8% |
| Q4 FY2019 | Dec 31, 2019 | $51.54M | +65.6% |
| Q3 FY2019 | Sep 30, 2019 | $74.67M | +49.9% |
| Q2 FY2019 | Jun 30, 2019 | $50.33M | -2.0% |
| Q1 FY2019 | Mar 31, 2019 | $54.38M | +2.4% |
| Q4 FY2018 | Dec 31, 2018 | $31.13M | -15.0% |
| Q3 FY2018 | Sep 30, 2018 | $49.80M | -1.2% |
| Q2 FY2018 | Jun 30, 2018 | $51.36M | -4.4% |
| Q1 FY2018 | Mar 31, 2018 | $53.10M | +13.0% |
| Q4 FY2017 | Dec 31, 2017 | $36.62M | +45.7% |
| Q3 FY2017 | Sep 30, 2017 | $50.39M | +9.6% |
| Q2 FY2017 | Jun 30, 2017 | $53.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $46.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $25.14M | – |
| Q3 FY2016 | Sep 30, 2016 | $45.96M | – |
See a number that looks wrong?